Reserve now
Thomas Gates, then McNeil's medical director, shot off a memo to the chief executive of Johnson & Johnson, the president of McNeil and other top officials, laying out a detailed "plan of action" for "diffusing media interest" in the research and "limiting the extent and duration of the coverage." Gates envisioned two possibilities: "Low Level of Publicity (most probable scenario)" and "High Level of Publicity (worst case scenario)." For the latter, Gates suggested a series of responses: a letter-writing campaign to medical societies, doctors, pharmacists and academics
Two RCTs [16, 33] involving 123 patients provided very low certainty evidence (Table 2) that L-carnitine supplementation has no difference in changes in the hs-CRP (MD: 1.03, 95%CI: 3.23 to 1.16)
The difference is convenience one vial instead of two, with both peptides in a fixed ratio
Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol
A consultation is still essential so we can review your health history, rule out anything that might make treatment unsuitable, and choose the right approach for your skin
